94
Participants
Start Date
August 31, 2003
Primary Completion Date
December 31, 2004
Study Completion Date
December 31, 2004
floxuridine
irinotecan hydrochloride
Memorial Sloan-Kettering Cancer Center, New York
University of Minnesota Cancer Center, Minneapolis
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences, Little Rock
Integris Oncology Services, Oklahoma City
Central Baptist Hospital, Lexington
Massachusetts General Hospital Cancer Center, Boston
Roswell Park Cancer Institute, Buffalo
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill
Comprehensive Cancer Center at Wake Forest University, Winston-Salem
University Medical Group, Providence
National Cancer Institute (NCI)
NIH
Alliance for Clinical Trials in Oncology
OTHER